|
1
|
Werhahn KJ: Epilepsy in the elderly. Dtsch
Arztebl Int. 106:135–142. 2009.PubMed/NCBI
|
|
2
|
Banerjee PN, Filippi D and Allen Hauser W:
The descriptive epidemiology of epilepsy-a review. Epilepsy Res.
85:31–45. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Benn EK, Hauser WA, Shih T, Leary L,
Bagiella E, Dayan P, Green R, Andrews H, Thurman DJ and Hesdorffer
DC: Estimating the incidence of first unprovoked seizure and newly
diagnosed epilepsy in the low-income urban community of Northern
Manhattan, New York City. Epilepsia. 49:1431–1439. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siddiqui A, Kerb R, Weale ME, Brinkmann U,
Smith A, Goldstein DB, Wood NW and Sisodiya SM: Association of
multidrug resistance in epilepsy with a polymorphism in the
drug-transporter gene ABCB1. N Engl J Med. 348:1442–1448. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zimprich F, SunderPlassmann R, Stogmann E,
Gleiss A, DalBianco A, Zimprich A, Plumer S, Baumgartner C and
Mannhalter C: Association of an ABCB1 gene haplotype with
pharmacoresistance in temporal lobe epilepsy. Neurology.
63:1087–1089. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hung CC, Tai JJ, Lin CJ, Lee MJ and Liou
HH: Complex haplotypic effects of the ABCB1 gene on epilepsy
treatment response. Pharmacogenomics. 6:411–417. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vahab SA, Sen S, Ravindran N, Mony S,
Mathew A, Vijayan N, Nayak G, Bhaskaranand N, Banerjee M and
Satyamoorthy K: Analysis of genotype and haplotype effects of ABCB1
(MDR1) polymorphisms in the risk of medically refractory epilepsy
in an Indian population. Drug Metab Pharmacokinet. 24:255–260.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Szoeke C, Sills GJ, Kwan P, Petrovski S,
Newton M, Hitiris N, Baum L, Berkovic SF, Brodie MJ, Sheffield LJ,
et al: Multidrug-resistant genotype (ABCB1) and seizure recurrence
in newly treated epilepsy: Data from international pharmacogenetic
cohorts. Epilepsia. 50:1689–1696. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lakhan R, Misra UK, Kalita J, Pradhan S,
Gogtay NJ, Singh MK and Mittal B: No association of ABCB1
polymorphisms with drug-refractory epilepsy in a north Indian
population. Epilepsy Behav. 14:78–82. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shahwan A, Murphy K, Doherty C, Cavalleri
GL, Muckian C, Dicker P, McCarthy M, Kinirons P, Goldstein D and
Delanty N: The controversial association of ABCB1 polymorphisms in
refractory epilepsy: An analysis of multiple SNPs in an Irish
population. Epilepsy Res. 73:192–198. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Seager J, Jamison DL, Wilson J, Hayward AR
and Soothill JF: IgA deficiency, epilepsy, and phenytoin treatment.
Lancet. 2:632–635. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kotsopoulos IA, van Merode T, Kessels FG,
de Krom MC and Knottnerus JA: Systematic review and meta-analysis
of incidence studies of epilepsy and unprovoked seizures.
Epilepsia. 43:1402–1409. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kwan P and Brodie MJ: Potential role of
drug transporters in the pathogenesis of medically intractable
epilepsy. Epilepsia. 46:224–235. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dombrowski SM, Desai SY, Marroni M,
Cucullo L, Goodrich K, Bingaman W, Mayberg MR, Bengez L and Janigro
D: Overexpression of multiple drug resistance genes in endothelial
cells from patients with refractory epilepsy. Epilepsia.
42:1501–1506. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rizzi M, Caccia S, Guiso G, Richichi C,
Gorter JA, Aronica E, Aliprandi M, Bagnati R, Fanelli R, D'Incalci
M, et al: Limbic seizures induce P-glycoprotein in rodent brain:
Functional implications for pharmacoresistance. J Neurosci.
22:5833–5839. 2002.PubMed/NCBI
|
|
16
|
Sisodiya S: Drug resistance in epilepsy:
Not futile, but complex? Lancet Neurol. 2:3312003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bodó A, Bakos E, Szeri F, Váradi A and
Sarkadi B: The role of multidrug transporters in drug availability,
metabolism and toxicity. Toxicol Lett. 140-141:133–143. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
MacDonald RL, Rogers CJ and Twyman RE:
Barbiturate regulation of kinetic properties of the GABAA receptor
channel of mouse spinal neurones in culture. J Physiol.
417:483–500. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Löscher W and Potschka H: Role of
multidrug transporters in pharmacoresistance to antiepileptic
drugs. J Pharmacol Exp Ther. 301:7–14. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sisodiya SM, Lin WR, Harding BN, Squier MV
and Thom M: Drug resistance in epilepsy: Expression of drug
resistance proteins in common causes of refractory epilepsy. Brain.
125:22–31. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maleki M, Sayyah M, Kamgarpour F,
Karimipoor M, Arab A, Rajabi A, Gharagozli K, Shamshiri AR and
Shahsavand AE: Association between ABCB1-T1236C polymorphism and
drug-resistant epilepsy in Iranian female patients. Iran Biomed J.
14:89–96. 2010.PubMed/NCBI
|
|
22
|
Haerian BS, Lim KS, Mohamed EH, Tan HJ,
Tan CT, Raymond AA, Wong CP, Wong SW and Mohamed Z: Lack of
association of ABCB1 haplotypes on five loci with response to
treatment in epilepsy. Seizure. 20:546–553. 2011. View Article : Google Scholar : PubMed/NCBI
|
